Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

103 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

NCT07309445

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 19 locations
View Trial Details
Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

NCT06319820

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • Genesis Research LLC Los Alamitos, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
View all 193 locations
View Trial Details
Recruiting

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

NCT05796375

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • West Haven VA Medical Center West Haven, Connecticut, United States
  • Bay Pines VA Healthcare System Bay Pines, Florida, United States
  • James A. Haley Veterans' Hospital Tampa, Florida, United States
  • VA Boston Jamaica Plains Campus West Roxbury, Massachusetts, United States
View Trial Details
Recruiting

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

NCT06503614

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Weill Cornell Medical Center New York, United States
View Trial Details
Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

NCT06995677

Conditions
Carcinoma, FGFR Gene Alterations, FGFR Gene Amplification, +18 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Tri Valley Urology - Murrieta Murrieta, California, United States
  • Eisenhower Medical Associates Rancho Mirage, California, United States
View all 48 locations
View Trial Details
Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

NCT06919965

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Academic Urology and Urogynecology of Arizona Sun City, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Colorado Clinical Research Lakewood, Colorado, United States
  • Georgia Urology Atlanta, Georgia, United States
View all 113 locations
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

NCT06637423

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0053) Bakersfield, California, United States
  • Moffitt Cancer Center ( Site 0057) Tampa, Florida, United States
  • Northwestern University ( Site 0051) Chicago, Illinois, United States
  • Johns Hopkins University ( Site 0055) Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Recruiting

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT06929286

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States
  • Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
View Trial Details

Related conditions